EMD Serono, Merck KGaA’s U.S. and Canada-based biopharmaceutical business, recently received Food and Drug Administration approval for a redesigned version of a pen injector, designed to be used to induce ovulation and pregnancy in certain oligo-anovulatory women.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion of AstraZeneca's and MedImmune's benralizumab, which is designed to treat adults with severe eosinophilic asthma.
AstraZeneca and MedImmune, its department for global biologics research and development, recently gave 28 presentations at the American Heart Association (AHA) Scientific Sessions, which took place Nov. 11-15 in Anaheim, California.
New surveys using data from ArthritisPower and CreakyJoints, part of the Global Healthy Living Foundation show women living with rheumatoid arthritis (RA) lack the information and resources to make confident decisions when it comes to reproductive health and family planning.
A study published in Nutrition & Diabetes shows that fruits blended in a NutriBullet provide the same glucose response as fruits consumed whole, which could be beneficial for people who need to monitor their glucose levels.
The Partnership to Fight Chronic Disease (PFCD) recently hosted a health observance briefing for National Diabetes Heart Connection Day to raise awareness of the link between diabetes and cardiovascular disease.
The American Medical Association (AMA) recently released a report that details how market concentration and consolidation is causing a trend of higher premiums for consumers and lower payments for physician services.
AbbVie plans to present data from 38 abstracts of Humira (adalimumab) and other products in the company’s investigational immunology medicine portfolio at the 2017 American College of Rheumatology (ACR)/Association for Rheumatology Health Professionals (ARHP) annual meeting Nov. 3-8, in San Diego.
Abbott said its Confirm Rx Insertable Cardiac Monitor (ICM), a smartphone compatible ICM to help physicians identify cardiac arrhythmias remotely, has been cleared by the U.S. Food and Drug Administration (FDA).
Massachusetts General Hospital (MGH) researchers recently found differences in gene transcription in immune cells that could help doctors determine which patients with the hepatitis C virus (HCV) develop chronic infection those whose immune systems can clear the virus.